<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>For many years, the development of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> has been seen as the core defect responsible for the development of Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>However, despite extensive research, the initial factors responsible for <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> development have not been elucidated </plain></SENT>
<SENT sid="2" pm="."><plain>If <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> can be overcome by enhanced insulin secretion, then <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e> will never develop </plain></SENT>
<SENT sid="3" pm="."><plain>Therefore, a β-cell defect is clearly required for the development of <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>There is a wealth of evidence to suggest that disorders in insulin secretion can lead to the development of decreased insulin sensitivity </plain></SENT>
<SENT sid="5" pm="."><plain>In this review, we describe the potential initiating defects in Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:mpath ids='MPATH_458'>normal</z:mpath> pulsatile insulin secretion and the effects that disordered secretion may have on both β-cell function and hepatic insulin sensitivity </plain></SENT>
<SENT sid="6" pm="."><plain>We go on to examine evidence from physiological and epidemiological studies describing β-cell dysfunction in the development of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Finally, we describe how disordered insulin secretion may cause intracellular <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and the implications this concept has for <z:mp ids='MP_0002055'>diabetes</z:mp> therapy </plain></SENT>
<SENT sid="8" pm="."><plain>In summary, disordered insulin secretion may contribute to development of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and hence represent an initiating factor in the progression to Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>